Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
Roche plans center in Pudong to boost medical R&D
Swiss pharmaceutical giant Roche announced it will build an 863 million yuan ($125.
Molecular Templates Announces Agreement with Takeda for the Joint Development of a Protein-Based Oncology Therapy
AUSTIN, Texas, Sept.
Lilly migraine drug wins European panel thumbs-up
(Reuters) - A European Medicines Agency panel on Friday recommended the approval of U.
Cambrex closes on $425M deal for dosage-form CDMO Halo Pharma
New Jersey-based Cambrex closed on its $425 million acquisition of dosage-form CDMO Halo Pharma and the two manufacturing plants picked up in the deal.
Diabetes drugs less affordable, less available in lower income countries
(Reuters Health) - People who live in low-income and middle-income countries may have a harder time finding and affording essential medicines for diabetes than residents of wealthier nations, ...
Astellas Announces Positive Topline Results for Global Phase 3 Trial of Roxadustat in Chronic Kidney Disease (CKD) Patients with Anemia not on Dialysis
TOKYO, September 20, 2018 - Astellas Pharma Inc.
EU approves fifth copy of AbbVie's $18 billion drug Humira
LONDON (Reuters) - Europe has approved a fifth copy of AbbVie’s $18-billion-a-year biologic drug Humira – the world’s best-selling prescription medicine – ramping up competition among ...
Allergan, Sosei suspend clinical development of dementia drug
Allergan and Sosei are voluntarily suspending clinical development activities with HTL0018318 pending investigation of an unexpected toxicology finding in an animal study involving non-human primates.
Cochrane Collaboration Expels Cofounder, Prompts Resignations
Physician Peter Gøtzsche, a board member of the organization, has been an outspoken critic of certain vaccines and of the pharma industry in general.
Actelion’s Opsumit shows promise in portopulmonary hypertension
Actelion has unveiled new data showing that the first ever randomised, controlled clinical trial investigating Opsumit as potential treatment for portopulmonary hypertension (PoPH) hit its pri...
Almirall steps into psoriasis market with Ilumetri approval
The European Commission has approved Almirall’s Ilumetri for moderate-to-severe chronic plaque psoriasis.
Phase III trial results of PT010 combination therapy in COPD
AstraZeneca has announced publication of results from the KRONOS Phase III trial which evaluated the efficacy and safety of triple combination therapy PT010 (budesonide/ glycopyrronium/formoterol ...
440
441
442
443
444
445
446
447
448